Charles River Laboratories (CRL) Tops Q3 EPS by 9c ; Offers Guidance
Tweet
Share
E-mail
Get Alerts CRL Hot Sheet
Price: $278.06 -1.28%
EPS Growth %: +21.8%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +21.8%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.43, $0.09 better than the analyst estimate of $2.34. Revenue for the quarter came in at $1 billion versus the consensus estimate of $987.43 million.
GUIDANCE:
Charles River Laboratories sees FY2025 EPS of $10.10-$10.30, versus the consensus of $10.19.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Lockheed Martin wins $871 million F-35 contract modification
- Empire Petroleum (EP) files $150M mixed shelf
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
